Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 23 of 95
Newsletters
Shareholders are putting more pressure on companies over environmental and social issues
By
David Meyer
and
Alan Murray
February 15, 2022
Politics
Canada’s ‘Freedom Convoy’ protesters block 2 more bridges to the U.S. in defiance of Trudeau’s new Emergencies Act powers
By
Jen Skerritt
,
Robert Tuttle
and
Bloomberg
February 15, 2022
Here’s how much the ‘Freedom Convoy’ has cost the U.S. and Canada
By
Megan Leonhardt
February 14, 2022
International
Police cleared Canada’s ‘Freedom Convoy’ protesters from the Ambassador Bridge, but truckers in Ottawa won’t budge
By
Eamon Barrett
February 14, 2022
Newsletters
Sometimes Super Bowl ads show someone has too much money to burn
By
David Meyer
and
Alan Murray
February 14, 2022
International
Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
By
Grady McGregor
February 14, 2022
Health
Is the COVID pandemic getting less deadly? The gap between cases and deaths is widening
By
Tom Randall
and
Bloomberg
February 14, 2022
Health
The program meant to help pregnant people safely find prescriptions to take has stalled
By
Kat Eschner
February 13, 2022
Health
From New York to the Netherlands, the (western) world is moving on from Omicron. Here’s where the big rollback is happening
By
Tristan Bove
February 12, 2022
Leadership
Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history
By
Carmela Chirinos
February 12, 2022
Health
FDA postpones meeting on Pfizer COVID shot for kids under 5
By
Fiona Rutherford
and
Bloomberg
February 11, 2022
Newsletters
Why engine maker Cummins is lobbying President Biden for new climate legislation
By
David Meyer
and
Alan Murray
February 11, 2022
China likely needs mRNA vaccines to reopen. Omicron boosters are a better bet
By
Grady McGregor
February 11, 2022
International
Why Canada’s ‘Freedom Convoy’ truckers, whose protest has blocked trade with the U.S., can’t just be towed away
By
Eamon Barrett
February 10, 2022
Health
CVS expects demand for COVID-19 tests and vaccines to fade as cases fall
By
Angelica Peebles
and
Bloomberg
February 9, 2022
Most Popular
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30...
By
Eleanor Pringle
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By
Jim Edwards
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By
Jordan Blum